Q4 2025
Released Feb 20, 2026, before the open
10-K filed Feb 20, 2026, 51 days after period end · 0000009326-26-000007
Q4 2025 · 10-K
Revenue$263.62M$263.62M +9.8% vs Q4 2024−1.5% vs Q3 2025
Net Income$39.23M$39.23M +16.8% vs Q4 2024−2.6% vs Q3 2025
EPS Diluted$1.21$1.21 +17.5% vs Q4 2024−2.4% vs Q3 2025
Gross Profit$93,899,000+8.8%
Operating Incomederived$52,290,000+10.2%
Operating Cash Flowderived$67,275,000+28.6%
Margins · derived
Gross margin35.6%−0.4 pt vs Q4 2024
Operating margin19.8%+0.1 pt vs Q4 2024
Net margin14.9%+0.9 pt vs Q4 2024
What the release said
The release
Same quarter
| Metric | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $263.62M | $240.00M | $228.70M | $232.53M |
| Net Income | $39.23M | $33.58M | $26.65M | $21.41M |
| EPS Diluted | $1.21 | $1.03 | $0.82 | $0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Balchem Corp · CIK 9326 · Engraved from SEC EDGAR